Press Releases
Press Releases
InVivo Therapeutics Requests Humanitarian Use Device Designation with FDA
InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that...
Press Releases
Kelsey-Seybold Named Nations First Accredited Accountable Care Organization
The National Committee for Quality Assurance (NCQA) announced today that Kelsey-Seybold Clinic is the first U.S. healthcare organization to receive accreditation as an Accountable Care...
Press Releases
Global Minimally Invasive Vertebral Compression Fracture Treatment Market to Show Moderate Growth
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, rising procedure volumes, driven by improving reimbursement and expanding demographic factors,...
Press Releases
British Columbia Ministry of Health Turns to McKesson for Provincial Radiology Peer Review Program
The British Columbia Ministry of Health has selected McKesson as vendor of choice for its radiologist peer review initiative, the single largest cross-facility initiative of...
Press Releases
Invacare Corporation Reports Expected Impact of Medical Device Excise Tax Based on IRS Final Rule
The Internal Revenue Service today issued final regulations on the 2.3% excise tax on medical devices that is part of the Affordable Care Act. ...
Press Releases
Ventas Declares Regular Quarterly Dividend of $0.62 Per Share
Ventas, Inc. said today that its Board of Directors declared a regular quarterly dividend of $0.62 per share, payable in cash on December 28, 2012...
Press Releases
HCA Announces Special Dividend of $2.00 per Share and Record and Payable Dates
HCA Holdings, Inc. today announced that its Board of Directors has approved a special cash dividend of $2.00 per share to be paid to shareholders...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.